SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-007530
Filing Date
2017-04-27
Accepted
2017-04-27 16:01:53
Documents
42
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20170331.htm 10-Q 1323873
2 EX-31.1 aldr-ex311_8.htm EX-31.1 15515
3 EX-31.2 aldr-ex312_7.htm EX-31.2 15541
4 EX-32.1 aldr-ex321_6.htm EX-32.1 8720
  Complete submission text file 0001564590-17-007530.txt   3578738

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldr-20170331.xml EX-101.INS 686297
6 XBRL TAXONOMY EXTENSION SCHEMA aldr-20170331.xsd EX-101.SCH 23531
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20170331_cal.xml EX-101.CAL 33033
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20170331_def.xml EX-101.DEF 38568
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20170331_lab.xml EX-101.LAB 162213
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20170331_pre.xml EX-101.PRE 117076
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 17788956
SIC: 2834 Pharmaceutical Preparations